Publications 2006

Publications of the year [1991] [1992] [1993] [1994] [1995] [1996] [1997] [1998] [1999] [2000] [2001] [2002] [2003] [2004] [2005] [2006] [all]

Asemissen, A.-M., U. Keilholz, S. Tenzer, M. Müller, S. Walter, S. Stevanovi, H. Schild, A. Letsch, E. Thiel, H.-G. Rammensee, C. Scheibenbogen. 2006. Identification of a highly immunogenic HLA-A*01-binding T-cell epitope of WT1. Clin. Cancer Res. 12:7476-7482.

Baechle, D., T. Flad, A. Cansier, H. Steffen, B. Schittek, J. Tolson, T. Herrmann, H. Dihazi, A. Beck, G.A. Mueller, M. Mueller, S. Stevanovi, C. Garbe, C.A. Mueller, H. Kalbacher. 2006. Cathepsin D is present in human eccrine sweat and involved in the postsecretory processing of the antimicrobial peptide DCD-1L. J. Biol. Chem. 281:5406-5415.

Boissel, N., D. Rea, V. Tieng, N. Dulphy, M. Brun, J.M. Cayuela, P. Rousselot, R. Tamouza, P. Le Bouteiller, F.-X. Mahon, A. Steinle, D. Charron, H. Dombret, A. Toubert. 2006. BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia. J. Immunol. 176:5108-5116.

Britten, C.M., C. Gouttefangeas, S. Kreiter. 2006. Cancer Immunotherapy 2005: Mainz, Germany, 12-13 May 2005. Cancer Immunol. Immunother. 55:475-480.

Bruder, D., A.K. Nussbaum, D.M. Gakamsky, M. Schirle, S. Stevanovi, H. Singh-Jasuja, A. Darji, T. Chakraborty, H. Schild, I. Pecht, S. Weiss. 2006.  Int. Immunol. 18:89-100.

Busche, A., T. Goldmann, U. Naumann, A. Steinle, S. Brandau. 2006. Natural killer cell-mediated rejection of experimental human lung cancer by genetic overexpression of major histocompatibility complex class I chain-related gene A. Human Gene Ther. 17:135-146.

Chalandon, Y., S. Degermann, J. Villard, L. Arlettaz, L. Kaiser, S. Vischer, S. Walter, M.H.M. Heemskerk, R.A.W. van Lier, C. Helg, B. Chapuis, E. Roosnek. 2006. Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications. Blood 107:389-396.

Decker, P. 2006. Nucleosome autoantibodies. Clinica Chim. Acta 366:48-60.

Decker, P., I. Kötter, R. Klein, B. Berner, H.-G. Rammensee. 2006. Monocyte-dervied dendritic cells over-express CD86 in patients with systemic lupus erythematosus. Rheumatology 45:1087-1095.

Dengjel, J., M.-D. Nastke, C. Gouttefangeas, G. Gitsioudis, O. Schoor, F. Altenberend, M. Müller, B. Krämer, A. Missiou, M. Sauter, J. Hennenlotter, D. Wernet, A. Stenzl, H.-G. Rammensee, K. Klingel, S. Stevanovi. 2006. Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas. Clin. Cancer Res. 12:4163-4170.

Dengjel, J., S. Stevanovi. 2006. Naturally presented MHC ligands carrying glycans. Transfus. Med. Hemother. 33:38-44.

Eisele, G., J. Wischhusen, M. Mittelbronn, R. Meyermann, I. Waldhauer, A. Steinle, M. Weller, M.A. Friese. 2006. TGF- and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells. Brain 129:2416-2425.

Falk, K., O. Rötzschke, S. Stevanovi, G. Jung, H.-G. Rammensee. 2006. Allele-specific motifs revealed by sequencing of self peptides eluted from MHC molecules. J. Immunol. 177:2741-2747.

Gückel, B., C. Rentzsch, M.-D. Nastke, A. Marmé, I. Gruber, S. Stevanovi, S. Kayser, D. Wallwiener. 2006. Pre-existing T-cell immunity against mucin-1 in breast cancer patients and healthy volunteers. J. Cancer Res. Clin. Oncol. 132:265-274.

Haselmayer, P., S. Tenzer, B.S. Kwon, G. Jung, H. Schild, M.P. Radsak. 2006. Herpes virus entry mediator synergizes with Toll-like receptor mediated neutrophil inflammatory response. Immunology 119:404-411.

Hillen, N., S. Stevanovi. 2006. Contribution of mass spectrometry-based proteomics to immunology. Expert Rev. Proteomics 3:653-664.

Holdenrieder, S., P. Stieber, A. Peterfi, D. Nagel, A. Steinle, H.R. Salih. 2006. Soluble MICA in malignant diseases. Int. J. Cancer 118:684-687.

Holdenrieder, S., P. Stieber, A. Peterfi, D. Nagel, A. Steinle, H.R. Salih. 2006. Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA. Cancer Immunol. Immunother. 55:1584-1589.

Knights, A.J., A.O. Weinzierl, T. Flad, B.-A. Guinn, L. Mueller, G.J. Mufti, S. Stevanovi, G. Pawelec. 2006. A novel MHC-associated Proteinase 3 peptide isolated from primary chronic myeloid leukaemia cells further supports the significance of this antigen for the immunotherapy of myeloid leukaemias. Leukemia 20:1067-1072.

Osterloh, P., K. Linkemann, S. Tenzer, H.-G. Rammensee, M.P. Radsak, D.H. Busch, H. Schild. 2006. Proteasomes shape the repertoire of T cells participating in antigen-specific immune responses. Proc. Natl. Acad. Sci. USA 103:5042-5047.

Pascolo, S. 2006. Vaccination with messenger RNA. Methods Mol. Med. 127:23-40.

Pawelec, G., S. Koch, C. Gouttefangeas, A. Wikby. 2006. Immunorejuvenation in the elderly. Rejuvenation Res. 9:111-116.

Pawelec, G., S. Koch, H. Griesemann, A. Rehbein, K. Hähnel, C. Gouttefangeas. 2006. Immunosenescence, suppression and tumour progression. Cancer Immunol. Immunother. 55:981-986.

Pereira, P., A. Boss, S. Clasen, C. Gouttefangeas, D. Schmidt, C.D. Claussen. 2006. Radiofrequency ablation: The percutaneous approach. Recent Results Cancer Res. 167:39-52.

Probst, J., S. Brechtel, B. Scheel, I. Hoerr, G. Jung, H.-G. Rammensee, S. Pascolo. 2006. Characterization of the ribonuclease activity on the skin surface. Genetic Vaccines Ther. 4:xxx-xxx.

Rammensee, H.-G. 2006. Peptides made to order. Immunity 25:693-695.

Rammensee, H.-G. 2006. Some considerations on the use of peptides and mRNA for therapeutic vaccination against cancer. Immunol. Cell Biol. 84:290-294.

Rechtsteiner, G., T. Warger, M. Hofmann, H.-G. Rammensee, H. Schild, M.P. Radsak. 2006. Precursor frequency can compensate for lower TCR expression in T cell competition during priming in vivo. Eur. J. Immunol. 36:2613-2623.

Rieg. S., S. Seeber, H. Steffen, A. Humeny, H. Kalbacher, S. Stevanovi, A. Kimura, C. Garbe, B. Schittek. 2006. Generation of multiple stable dermcidin-derived antimicrobial peptides in sweat of different body sites. J. Inv. Derm. 126:354-365.

Röck, F., S. Mueller, U. Weimar, H.-G. Rammensee, P. Overath. 2006. Comparative analysis of volatile constituents from mice and their urine. J. Chem. Ecol. 32:1333-1346.

Rönnefarth, V.M., A.I.M. Erbacher, T. Lamkemeyer, J. Madlung, A. Nordheim, H.-G. Rammensee, P. Decker. 2006. TLR2/TLR4-independent neutrophil activation and recruitment upon endocytosis of nucleosomes reveals a new pathway of innate immunity in systemic lupus erythematosus. J. Immunol. 177:7740-7749.

Rückrich, T., J. Brandenburg, A. Cansier, M. Müller, S. Stevanovi, K. Schilling, B. Wiederanders, A. Beck, A. Melms, M. Reich, C. Driessen, H. Kalbacher. 2006. Specificity of human cathepsin S determined by processing of peptide substrates and MHC class II-associated invariant chain. Biol. Chem. 387:1503-1511.

Salih, H.R., D. Goehlsdorf, A. Steinle. 2006. Release of MICB molecules by tumor cells: Mechanism and soluble MICA in sera of cancer patients. Hum. Immunol. 67:188-195.

Scheel, B., S. Aulwurm, J. Probst, L. Stitz, I. Hoerr, H.-G. Rammensee, M. Weller, S. Pascolo. 2006. Therapeutic anti-tumor immunity triggered by injections of immunostimulating single-stranded RNA. Eur. J. Immunol. 36:2807-2816.

Schmid, D., J. Dengjel, O. Schoor, S. Stevanovi, C. Münz. 2006. Autophagy in innate and adaptive immunity against intracellular pathogens. J. Mol. Med. 84:194-202.

Schreiner, B., J. Voss, J. Wischhusen, Y. Dombrowski, A. Steinle, H. Lochmüller, M. Dalakas, A. Melms, H. Wiendl. 2006. Expression of toll-like receptors by human muscle cells in vitro and in vivo: TLR3 is highly expressed in inflammatory and HIV myopathies, mediates IL-8 release and up-regulation of NKG2D-ligands. The FASEB J. 20:118-120.

Spreu, J., T. Stehle, A. Steinle. 2006. Human cytomegalovirus-encoded IL16 discriminates MIC molecules by their a2 domains. J. Immunol. 177:3143-3149.

Sun, Y., S. Stevanovi, M. Song, A. Schwantes, C.J. Kirkpatrick, D. Schadendorf, K. Cichutek. 2006. The kinase insert domain-containing receptor is an angiogenesis-associated antigen recognized by human cytotoxic T lymphocytes. Blood 107:1476-1483.

Szurman, P., R. Kaczmarek, M.S. Spitzer, G.B. Jaissle, P. Decker, S. Grisanti, S. Henke-Fahle, S. Aisenbrey, K.U. Bartz-Schmidt. 2006. Differential toxic effect of dissolved triamcinolone and its crystalline deposits on cultured human retinal pigment epithelium (ARPE19) cells. Exp. Eye Res. 83:584-592.

Trautwein, M., C. Schindler, R. Gauss, J. Dengjel, E. Hartmann, A. Spang. 2006. Arf1p, Chs5p and the ChAPs are required for export of specialized cargo from the Golgi. The EMBO J. 25:943-954.

Voss, S., S. Welte, M. Fotin-Mleczek, R. Fischer, A.J. Ulmer, G. Jung, K.-H. Wiesmüller, R. Brock. 2006. A CD14 domain with lipopolysaccharide-binding and neutralizing activity. Chem. Biochem. 7:275-286.

Waldhauer, I., A. Steinle. 2006. Proteolytic release of soluble UL16-binding protein 2 from tumor cells. Cancer Res. 66:2520-2526.

Warger, T., N. Hilf, G. Rechtsteiner, P. Haselmayer, D.M. Carrick, H. Jonuleit, P. von Landenberg, H.-G. Rammensee, C.V. Nicchitta, M.P. Radsak, H. Schild. 2006. Interaction of TLR2 and TLR4 ligands with the N-terminal domain of GP96 amplifies innate and adaptive immune responses. J. Biol. Chem. 281:22545-22553.

Weinzierl, A., S. Stevanovi. 2006. LC-MS-based protein and peptide quantifications using stable isotope labels: From ICTA in general to differential N-terminal coding (dNIC) in particular. Biotech Genet. Eng. Rev. 23:21-39.

Welte, S., S. Kuttruff, I. Waldhauer, A. Steinle. 2006. Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction. Nature Immunol. 22:xxx-xxx.

Zhang, Z., T. Weinschenk, K. Guo, H.J. Schluesener. 2006. siRNA binding proteins of microglial cells: PKR is an unanticipated ligand. J. Cell. Biochem. 97:1217-1229.

  We are on the run ...